Create Alert
Watchlist
0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Analyst Estimates

58%
Buy
58%
Hold
16%
Sell
26%
Aggregated by Refinitiv from 19 Analysts

Fundamentals

Market Cap₹42,543Cr
ROE5.17%
P/E Ratio(TTM)41.59
EPS(TTM)8.52
P/B Ratio2.15
Dividend Yield0.14%
Industry P/E37.11
Book Value164.77
Debt to Equity0.82
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Biocon

Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.;
Parent OrganisationBiocon Limited
Managing DirectorMr. Siddharth Mittal
NSE SymbolBIOCON

Shareholding Pattern

Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Promoters
60.64%
Retail And Others
20.05%
Mutual Funds
8.57%
Foreign Institutions
5.63%
Other Domestic Institutions
5.11%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Syngene International
NA
(0.00%)
58.74
Advanced Enzyme Technologies
NA
(0.00%)
31.53
Suven Life Sciences
NA
(0.00%)
-28.36
Remus Pharmaceuticals
NA
(0.00%)
71.13
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW